Arno Therapeutics, Inc.

Arno Therapeutics is a biopharmaceutical company focused on creating value through the development of innovative products for the treatment of cancer patients. Arno has exclusive worldwide rights to develop and market three innovative pre-clinical and clinical-stage product candidates with unique mechanisms of action. These compounds have the potential to be first-in-class products for the treatment of hematologic malignancies and solid tumors.